海外の治験の状況「1」での検索結果
10032件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- A Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Dapagliflozin as an Add-on to Insulin Therapy in Subjects With Type 1 Diabetes Mellitus - Study Two
- Diabetes;E10 - Insulin-dependent diabetes mellitus
- Argentina, Belarus, Belgium, Canada, Chile, Germany, Japan, Netherlands, Poland, Russian Federation, Sweden, Switzerland, United Kingdom, United States
- 2016-01-28
Recruiting
- Derivation of New Human Embryonic Stem Cell Lines Lines for Clinical Use
- Infertility
- Israel
- 2006-07-16
Not recruiting
- Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced RCC Who Have Failed First-Line Sunitinib
- Renal Cell Carcinoma;Renal Cell Carcinoma;Renal Cell Carcinoma;Renal Cell Carcinoma
- Argentina, Australia, Austria, Canada, Chile, China, Denmark, Finland, France, Germany, Hong Kong, Hungary, Italy, Korea, Republic of, Netherlands, Singapore, Spain, Sweden, Switzerland, United Kingdom, United States
- 2007-05-15
Not recruiting
- Comparison of On-line and Off-line Measurements of Exhaled Nitric Oxide (NO)
- Asthma;Primary Ciliary Dyskinesia
- Israel
- 2008-05-26
Not Recruiting
- Efficacy and safety of adding LX4211 (an investigational oral compound) for patients with Type 1 Diabetes Mellitus (T1D) who have inadequate control of their blood glucose (sugar) levels on insulin alone.
- Type 1 Diabetes Mellitus br>MedDRA version: 17.1 Level: PT Classification code 10067584 Term: Type 1 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Austria, Belgium, Bulgaria, France, Germany, Hungary, Israel, Italy, Lithuania, Netherlands, Poland, Romania, Slovakia, Spain, Sweden, Switzerland, United Kingdom
- 2015-03-05
Not Recruiting
- A prospective Phase IV study at different centers without any competitor,Single dose clinical study to assess the safety and efficacy of glabellar lines DYSPORT® in adult subjects for treatment of glabellar lines moderate-to-severe the area on frontal bone above the nose and between the eyebrows
- lines between the area on the frontal bone above the nasion and between the eyebrows.
- India
- 2018-11-15
Recruiting
- Repeated phase III randomized vaccine trial of single dose of the gentamicin-attenuated line of Leishmania major H-line against cutaneous leishmaniasis in in Vrznh in Isfahan Province and Zrghan in Fars Provinces.
- Leishmaniasis. Cutaneous leishmaniasis
- Iran (Islamic Republic of)
- 2018-11-08
Not Recruiting
- Evaluation of the association between the Gingival Line Angle with the Gingival and Interdental Smile Line among males and females.
- Periodontally and systemically healthy volunteers
- India
- 2018-10-03
Recruiting
- Clinical study of apatinib mesylate combined with paclitaxel in second-line and second-line maintenance of advanced gastric cancer
- gastric cancer
- China
- 2018-07-18
Not Recruiting
- Comparison for Anlotinib Hydrochloride with standard second-line chemotherapy in the treatment of non small-cell lung cancer with first-line treatment failure
- non small-cell lung cancer
- China
- 2019-02-01
Recruiting
- Single-arm exploratory study for Sintilimab second-line or later-line treatment of advanced non-small cell lung cancer with DDR pathway gene mutation
- Non-Small Cell Lung Cancer
- China
- 2019-05-17
Recruiting
- To investigate the relationship between gene polymorphism of GLP-1 signaling pathway and pharmacotherapy phenotype, and to explore the precise treatment of type 2 diabetes mellitus of GLP-1 RAs with SNP chip technology.
- type 2 diabetes mellitus
- China
- 2019-08-05
Recruiting
- To observe the comparison of efficacy of amroitinib combined with first-line chemotherapy and first-line chemotherapy alone in preoperative neoadjuvant therapy for stage IIIA non-small cell lung cancer
- Lung Cancer
- China
- 2019-10-16
Recruiting
- Retrospective Analysis of 2nd-line Nab-Paclitaxel + Gemcitabine After 1st-line FOLFIRINOX in Pancreatic Cancer
- Pancreatic Cancer;Metastatic Pancreatic Cancer
- Korea, Republic of
- 2019-10-17
Recruiting
- MT10109L in the Long-term, Open-label Treatment of Glabellar Lines and Lateral Canthal Lines
- Glabellar Lines;Lateral Canthal Lines
- Belgium, Canada, Germany, Russian Federation, United Kingdom, United States
- 2019-10-23
Recruiting
- Effect of an Exercise on Serum Uncoupling Protein-1 Level and the Role of Uncoupling Protein-1-3826 A/G Polymorphism
- Uncoupling Protein-1;Polymorphism, Restriction Fragment Length;Irisin
- Turkey
- 2019-11-04
Not recruiting
- Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes
- Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus
- Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Hungary, Israel, Italy, Mexico, Romania, Spain, Sweden, United Kingdom, United States
- 2014-10-15
Not Recruiting
- Effects of audio-visual training on marriage in patients with type one diabetes
- Insulin-dependent diabetes mellitus. br>Insulin-dependent diabetes mellitus;Insulin-dependent diabetes mellitus
- Iran (Islamic Republic of)
- 2014-06-24
Not recruiting
- Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes
- Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus
- Argentina, Belarus, Belgium, Canada, Chile, Germany, Japan, Netherlands, Poland, Russian Federation, Sweden, Switzerland, United Kingdom, United States
- 2015-06-01
Not Recruiting
- Mobile Based Bolus Calculator for Diabetes Treatment
- Insulin-dependent diabetes mellitus. br>Insulin-dependent diabetes mellitus;Insulin-dependent diabetes mellitus
- Iran (Islamic Republic of)
- 2015-02-06